Clinical Trial Update: Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation

View source ↗

Summary

An observational prospective trial evaluating VizAblate intrauterine RF ablation for symptomatic uterine fibroids has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia
• Uterine Fibroids

Drugs mentioned

• VizAblate

Snippet

Sponsor: Gynesonics | Conditions: Menorrhagia, Leiomyoma | Status: TERMINATED